Jonathan Krog

Jonathan Krog

Auto-generated profile, based on publicly available information

Jonathan Krog

Massachusetts Institute of Technology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Journal of Theoretical Biology
Verified
Journal Article
Open access
MCMichael G. Cortes
Michael G. Cortes
JKJonathan Krog
Jonathan Krog
Gábor BalázsiGábor Balázsi
Gábor Balázsi
Lysogens are bacterial cells that have survived after genomically incorporating the DNA of temperate bacteriophages infecting them. If an infection results in lysogeny, the lysogen continues to grow and divide normally, seemingly unaffected by the integrated viral genome known as a prophage. However, the prophage can still have an impact on the host's phenotype and overall fitness in certain environments. Additionally, the prophage within the lysogen can activate the lytic pathway via spontaneous prophage induction (SPI), killing the lysogen and releasing new progeny phages. These new phages can then lyse or lysogenize other susceptible nonlysogens, thereby impacting the competition between lysogens and nonlysogens. In a scenario with differing growth rates, it is not clear whether SPI would be beneficial or detrimental to the lysogens since it kills the host cell but also attacks nonlysogenic competitors, either lysing or lysogenizing them. Here we study the evolutionary dynamics of a mixture of lysogens and nonlysogens and derive general conditions on SPI rates for lysogens to displace nonlysogens. We show that there exists an optimal SPI rate for bacteriophage λ and explain why it is so low. We also investigate the impact of stochasticity and conclude that even at low cell numbers SPI can still provide an advantage to the lysogens. These results corroborate recent experimental studies showing that lower SPI rates are advantageous for phage-phage competition, and establish theoretical bounds on the SPI rate in terms of ecological and environmental variables associated with lysogens having a competitive advantage over their nonlysogenic counterparts.

27 August 2025 in bioRxiv
Verified
Preprint
Open access
SGStephanie A Gaglione
Stephanie A Gaglione
JKJonathan Krog
Jonathan Krog
FKFrances R Keer
Frances R Keer
EFEmma N Finburgh
Emma N Finburgh
EKElif Kulaksizoglu
Elif Kulaksizoglu
MBMichael E Birnbaum
Michael E Birnbaum
T cell receptor (TCR) specificity is central to the efficacy of T cell therapies, yet scalable methods to map how TCR sequences shape antigen recognition remain limited. To address this, we introduce VelociRAPTR, a library-on-library approach that combines yeast-displayed TCR libraries with pMHC-displaying virus-like particles (pMHC-VLPs) to rapidly screen millions of TCR-antigen interactions. We show that pMHC-VLPs efficiently bind TCRs on yeast and generate equivalent data to recombinantly produced pMHC protein. We then apply VelociRAPTR to screen 47 million variants of the A6 and 868 TCRs against 92 pMHCs simultaneously, mutating both the CDR3 loops and cognate peptides. The resulting CDR3-pMHC maps reveal biased recognition patterns, where mutations to CDR3 loops can selectively constrain or broaden specificity to peptide analogs. These insights provide a foundation for engineering TCRs with defined pMHC binding profiles and improving models that predict TCR-antigen interactions, including the prediction of off-target recognition. By coupling the scale of yeast display with the modularity of VLPs, VelociRAPTR offers a generalizable strategy for generating deep, high-throughput protein-protein interaction data.

16 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
BCBrandon Carter
Brandon Carter
JKJonathan Krog
Jonathan Krog
MBMichael E. Birnbaum
Michael E. Birnbaum
DGDavid K. Gifford
David K. Gifford
T cells mediate immune responses against pathogens and cancer through T cell receptors (TCRs) that recognize foreign peptides presented on the cell surface by Major Histocompatibility Complex (MHC) proteins. TCRs carry enormous diversity and differ across individuals, and mechanisms that determine TCR-pMHC binding are poorly understood. The ability to predict TCR-pMHC interactions would accelerate development of cellular therapeutics to design TCRs that specifically bind to a target of interest. We designed a randomized library of 19 6 TCR CDR3 β sequences and experimentally evaluated their affinities for the Tax-A02 peptide-MHC target. We trained ML models that predict TCR binding to Tax-A02 from TCR sequence and used model interpretation to identify TCR sequence features associated with binding. We found these features accurately mirror the true sequence features in our experimental data.